Semaglutide is a proven, FDA-approved GLP-1 agonist for weight loss (1520% body weight reduction in clinical trials) Tirzepatide is a dual GIP/GLP-1 agonist showing up to 22% weight loss in trials often more potent than Semaglutide for some patients Retatrutide is an experimental triple agonist with promising early results, but is NOT FDA-approved and not yet available at Better Med Spa All three require medical supervision, lifestyle changes, and ongoing monitoring for safe, sustainable results Better Med Spa in Lincoln Park currently offers Semaglutide and Tirzepatide with physician-directed protocols, slow titration, and holistic wellness integration Quick Comparison: Semaglutide vs
Of these, 84% were women, with a median BMI of 42 kg/m 2 at the time of bariatric surgery
High-Protein, Low-Carb Eating This meal plan isnt about restriction
Energy Metabolism as a Therapeutic Target in Cancer: The Role of Coenzyme Q10
Additional changes in 2025 Beginning Jan
And that would help induce what fasting would already do or it would help accentuate the benefits of fasting, said Sinclair on an Instagram Live